Loading...
XHKG
1666
Market cap840mUSD
Jun 06, Last price  
5.12HKD
1D
0.39%
1Q
7.11%
Jan 2017
-64.39%
IPO
668.00%
Name

Tong Ren Tang Technologies Co.

Chart & Performance

D1W1MN
P/E
11.58
P/S
0.83
EPS
0.41
Div Yield, %
3.86%
Shrs. gr., 5y
—
Rev. gr., 5y
10.15%
Revenues
7.26b
+7.18%
1,135,678,0001,034,768,0001,157,030,0001,211,455,0001,307,897,0001,578,914,0001,936,418,0002,447,132,0002,910,749,0003,341,166,0004,066,960,0004,665,295,0005,025,183,0005,059,638,0004,476,449,0004,607,369,0005,400,487,0005,991,841,0006,773,463,0007,259,644,000
Net income
522m
-11.59%
231,186,000143,456,000153,520,000160,528,000173,027,000198,342,000254,687,000330,171,000390,093,000462,187,000540,481,000595,654,000666,666,000677,815,000417,650,000467,553,000507,249,000582,888,000590,188,000521,794,999
CFO
0k
-100.00%
164,654,000127,391,000-42,264,000115,851,000231,293,000266,837,000255,830,000401,648,000375,451,000333,875,000303,843,000410,005,000679,807,000985,236,0001,051,775,000435,810,0001,033,415,000723,769,000554,175,0000
Dividend
Jun 14, 20240.19776 HKD/sh
Earnings
Jun 11, 2025

Profile

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
URL
https://www.tongrentangkj.com/
IPO date
Oct 31, 2000
Employees
4,030
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
7,259,644
7.18%
6,773,463
13.04%
5,991,841
10.95%
Cost of revenue
6,354,271
5,757,881
4,869,304
Unusual Expense (Income)
NOPBT
905,373
1,015,582
1,122,537
NOPBT Margin
12.47%
14.99%
18.73%
Operating Taxes
174,278
170,142
210,373
Tax Rate
19.25%
16.75%
18.74%
NOPAT
731,095
845,440
912,164
Net income
521,795
-11.59%
590,188
1.25%
582,888
14.91%
Dividends
(202,909)
(204,925)
Dividend yield
2.42%
2.83%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,142,236
151,320
298,468
Long-term debt
1,453,888
1,647,006
1,344,413
Deferred revenue
132,584
112,534
Other long-term liabilities
119,066
(119,746)
Net debt
(1,901,305)
(2,481,649)
(2,582,401)
Cash flow
Cash from operating activities
554,175
723,769
CAPEX
(103,393)
(157,916)
Cash from investing activities
(1,067,527)
43,009
Cash from financing activities
(497,759)
(499,447)
FCF
(254,830)
158,361
435,827
Balance
Cash
4,381,271
4,237,936
4,182,500
Long term investments
116,158
42,039
42,782
Excess cash
4,134,447
3,941,302
3,925,690
Stockholders' equity
10,165,079
9,651,885
9,016,938
Invested Capital
8,574,909
7,470,381
6,643,983
ROIC
9.11%
11.98%
14.21%
ROCE
7.12%
8.89%
10.61%
EV
Common stock shares outstanding
1,280,784
1,280,784
1,280,784
Price
5.19
-20.76%
6.55
15.93%
5.65
-32.58%
Market cap
6,647,269
-20.76%
8,389,135
15.93%
7,236,430
-32.58%
EV
7,704,846
8,669,954
7,188,216
EBITDA
905,373
1,292,728
1,384,259
EV/EBITDA
8.51
6.71
5.19
Interest
45,053
53,798
Interest/NOPBT
4.44%
4.79%